The Role of Immunosuppression in Ex Vivo Lung Perfusion: A Systematic Review
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.08.007 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Ryaan El-Andari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Lung, Perfusion, Lung Transplantation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
BACKGROUND: Ex vivo lung perfusion (EVLP) allows for prolonged preservation of donor lungs; however, inflammation during EVLP has been a persistent concern, despite previous attempts to minimize inflammation. Herein, we perform a systematic review investigating the efficacy of various approaches to reducing immune response and inflammation during EVLP. METHODS: A literature search of PubMed and Embase was conducted, including all articles describing all human or animal investigations of immunosuppression or proinflammatory cytokine inhibition in the settings of EVLP. RESULTS: A total of 643 articles were identified, and 19 met the inclusion criteria. Among these, models utilized were 10 porcine, 5 rat, 1 murine, 1 rabbit, and 2 human studies, representing a combined total of 411 subjects. Complement inhibition consistently improved oxygenation. IL-10 gene therapy reduced IL-1β, IL-6, and IL-8 while increasing IL-10, translating into lower pulmonary vascular resistance, improved oxygenation, and reduced edema. Cyclosporine reduced IL-1β and IL-6 and improved oxygenation at low doses but was detrimental at higher doses. Antiinflammatory modulation broadly decreased IL-6, IL-1β, IL-10, INF-γ, IL-18, and TNFα, with improvements in compliance and reduced airway pressures. Finally, adenosine A2A receptor agonists consistently reduced TNFα and INF-γ, lowered pulmonary artery pressure, increased compliance, and reduced edema. CONCLUSIONS: This systematic review identified numerous studies with various approaches that aim to reduce inflammation during EVLP. The majority of the methods investigated improved select measures of lung function, with no single approach resulting in widespread improvements. A combination of immunosuppressive or antiinflammatory interventions may be required to adequately address the inflammatory response during EVLP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- University of Alberta, Edmonton, Alberta, Canada.
- Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. Electronic address: jayan@ualberta.ca.
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
El-Andari, R., Machhiwala, M., Hassanzadeh, P., Lam, A., Palmer, A., Halloran, K., Nagendran, J., Freed, D. H., & Nagendran, J. (2026). The Role of Immunosuppression in Ex Vivo Lung Perfusion: A Systematic Review. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.08.007
Vancouver
El-Andari R, Machhiwala M, Hassanzadeh P, Lam A, Palmer A, Halloran K, et al. The Role of Immunosuppression in Ex Vivo Lung Perfusion: A Systematic Review. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.08.007
BibTeX
@article{ElAndari2026,
author = {El-Andari, Ryaan and Machhiwala, Maira and Hassanzadeh, Parham and Lam, Adrien and Palmer, Avery and Halloran, Kieran and Nagendran, Jeevan and Freed, Darren H and Nagendran, Jayan},
title = {The Role of Immunosuppression in Ex Vivo Lung Perfusion: A Systematic Review},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.08.007}
}
EUVIMED